N-acetylcysteine does not prevent bronchopulmonary dysplasia in immature infants: a randomized controlled trial
| Autor: | Kristin Lossius, Gitte Esberg, Lennart Stigson, Terhi Ahola, Vineta Fellman, Bo Selander, Tom Stiris, Sören Stövring, Kristina Virkola, Risto Lapatto, Baldvin Jonsson, Sveinn Kjartansson, Kari O. Raivio, Finn Jonsbo |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2003 |
| Předmět: |
Male
Pediatrics medicine.medical_specialty medicine.medical_treatment Placebo Antioxidants law.invention Double-Blind Method Randomized controlled trial law mental disorders medicine Humans Infant Very Low Birth Weight Continuous positive airway pressure Infusions Intravenous Bronchopulmonary Dysplasia business.industry Infant Newborn Gestational age Retinopathy of prematurity medicine.disease Low birth weight Bronchopulmonary dysplasia Anesthesia Pediatrics Perinatology and Child Health Necrotizing enterocolitis Cystine Female medicine.symptom business Infant Premature |
| Zdroj: | Ahola, T, Lapatto, R, Raivio, K O, Selander, B, Stigson, L, Jonsson, B, Jonsbo, F, Esberg, G, Støvring, S, Kjartansson, S, Stiris, T, Lossius, K, Virkola, K & Fellman, V 2003, ' N-acetylcysteine does not prevent bronchopulmonary dysplasia in immature infants: a randomized controlled trial ' J Pediatr, vol. 143, no. 6, pp. 713-719 . |
| Popis: | Objective To evaluate whether N-acetylcysteine (NAC) infusion during the first week of life reduces the risk of death or bronchopulmonary dysplasia (BPD) in infants with extremely low birth weight. Study design In a Nordic multicenter, double-blind trial, infants (n = 391) weighing 500 to 999 g and on ventilator or nasal continuous positive airway pressure were randomized before the age of 36 hours to receive NAC 16 to 32 mg/kg/d (n = 194) or placebo (n = 197) intravenously for 6 days. Primary end points were death or BPD, defined as supplementary oxygen requirement at 36 weeks' gestational age. Results There was no difference in the combined incidence of the primary end points death or BPD, 51% vs. 49%, between the NAC group and control group. Also similar was the incidence of BPD in survivors at 36 weeks' gestational age, 40% vs. 40%, and the mean oxygen requirement at the age of 28 days, 31.2% vs. 30.7%, respectively. The severity of BPD was similar in both groups. Conclusions A 6-day course of intravenous N-acetylcysteine at the dosage used does not prevent BPD or death in infants with extremely low birth weight. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|